Healthcare - Biotechnology - NASDAQ - US
$ 4.85
-8.66 %
$ 194 M
Market Cap
-1.6
P/E
INCOME STATEMENT
0
REVENUE
-104 M
OPERATING INCOME
-96 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Solid Biosciences Inc.
| Revenue | 0 |
| Cost Of Revenue | 76.6 M |
| Gross Profit | -76.6 M |
| Operating Expenses | 104 M |
| Operating Income | -104 M |
| Other Expenses | -8.3 M |
| Net Income | -96 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 0 | 8.1 | 13.6 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 76.6 | 2.4 | 58.7 | 3.9 | 2.8 | 1.6 | 0.4 | 56 K | 0 |
| Gross Profit | (76.6) | 5.7 | (45.1) | (3.9) | (2.8) | (1.6) | (0.4) | 56 K | 0 |
| OPERATING INCOME | |||||||||
| Operating Expenses | 104.3 | 107.4 | 85.9 | 86.5 | 119.3 | 75.7 | 54.9 | 25.6 | 6.6 |
| Selling, General and Administrative Expenses | 27.8 | 28.9 | 27.1 | 21.6 | 24.6 | 17.7 | 15.0 | 5.5 | 2.4 |
| Research and Development Expenses | 76.6 | 78.4 | 58.7 | 64.9 | 94.7 | 58.0 | 39.9 | 20.1 | 4.2 |
| Operating Income | (104.3) | (106.5) | (72.3) | (88.4) | (119.3) | (75.7) | (54.9) | (25.6) | (6.6) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 8.3 | 20.5 | 66 K | (1.8) | 2.1 | 0.9 | 1.7 | 1.8 | 100 K |
| Pre-Tax Income | (96.0) | (86.0) | (72.2) | (88.3) | (117.2) | (74.8) | (53.2) | (23.8) | (6.7) |
| NET INCOME | |||||||||
| Tax Provision | 0 | (20.5) | 64 K | 1.8 | (1.6) | 0.9 | (1.3) | (2.6) | (0.3) |
| Net Income | (96.0) | (65.5) | (72.1) | (90.1) | (115.6) | (74.8) | (52.1) | (21.5) | (6.4) |
| EPS | 4.83 | 7.7 | 10.1 | 26 | 43 | 33.7 | 24.3 | 16.8 | 4.97 |